Babylon Health Virtual Care Platform
AI-powered telemedicine and virtual care platform
Platform · Cloud SaaSCompany source
Company profile
About Babylon Health
Babylon Health was a pioneering digital healthcare company that combined artificial intelligence with telemedicine to deliver accessible healthcare services. Founded with the mission to make quality healthcare affordable and accessible globally, Babylon developed an AI-powered platform that enabled patients to check symptoms, consult with doctors remotely, and manage their health through a mobile application. The company's technology integrated machine learning algorithms for symptom assessment with video consultations, allowing users to receive medical advice and prescriptions without visiting physical clinics. Babylon partnered with health systems, insurers, and governments to deliver virtual care services across multiple markets. The platform aimed to reduce healthcare costs while improving access, particularly for underserved populations. At its peak, Babylon served millions of users across several countries and became one of the most prominent digital health companies globally. However, the company faced significant financial challenges and operational difficulties that ultimately led to its restructuring and asset sales in 2023-2024.
Company description Babylon Health official website
Primary marketTelemedicine & Virtual Care
Commercial modelCommercial information available on request
Work at Babylon Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- chronic disease management
- mental health
- primary care
- urgent care
Who it serves
- Consumers
- Government
- Health Systems
- Payers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsCanada · Rwanda · United Kingdom · United States · various international markets
Company sourceOfficial website
Company milestones
Platform expansion
Company underwent significant restructuring and asset sales in 2023-2024 following financial difficulties
Partnerships
Recorded partners
- government health programs
- NHS
- various health insurers
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Therapeutic Effect of Niclosamide versus Triamcinolone on Rabbit Ear Model of Hypertrophic Scar.Aesthetic plastic surgery · Jul 8, 2026
Counteractive Effects of Diarylpropionitrile on Testosterone-Induced Benign Prostatic Hyperplasia in Rats via Targeting Key Androgenic, Angiogenic, Proliferative, and Inflammatory Mechanisms.Drug research · Feb 26, 2026
Assessment of coated orthodontic miniscrews with chlorhexidine hexametaphosphate antimicrobial nanoparticles: A randomized clinical trial.Journal of the World federation of orthodontists · Apr 1, 2025
Hepatoprotective role of vildagliptin in CLP-induced sepsis in mice.Wiadomosci lekarskie (Warsaw, Poland : 1960) · Jan 1, 2025
Global Practice Patterns and Variations in the Medical and Surgical Management of Non-Obstructive Azoospermia: Results of a World-Wide Survey, Guidelines and Expert Recommendations.The world journal of men's health · Jan 1, 2025
Girls' Self-Esteem and its Association with Self-Stigma toward Obesity.Iranian journal of nursing and midwifery research · Jan 1, 2025
Clinical validation
Clinical-trial records
Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate PathwayNCT03361618 · Sponsor · COMPLETED
Study of the Effect of Oral Zinc Supplementation on Superoxide Radical ScavengersNCT02217189 · Sponsor · COMPLETED
The Effect of Oral Zinc Supplementation on Thiol Oxido-reductive IndexNCT02985905 · Sponsor · COMPLETED
Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide PathwayNCT01684059 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Babylon Health
Recent articles published on Babylon Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Telemedicine & Virtual Care
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.